Science Outreach-YINFENG LIFE EXTENSION PROGRAM

EN丨CN

International Life Extension Research Alliance

Domestic and International Exchange Dynamics

Video Center

【The YinFeng Life Continuation Project Debuts at the 2026 Annual Meeting of the Chinese Medical Association's Medical Ethics Branch—Ethics Leading Biotech Toward Benevolent Innovation】

Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross

Yinfeng Life Science Research Institute, in Collaboration with University of Science and Technology of China, Develops CryoSIM Platform, Published in Top Analytical Chemistry Journal Revolutionizing Oocyte Membrane Permeability Analysis Technology

Public Welfare Partnership: A Special Letter from the Jinan Red Cross

Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference

【The YinFeng Life Continuation Project Debuts at the 2026 Annual Meeting of the Chinese Medical Association's Medical Ethics Branch—Ethics Leading Biotech Toward Benevolent Innovation】

2026/07/22

The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.

Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross

2026/04/24

Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.

Yinfeng Life Science Research Institute, in Collaboration with University of Science and Technology of China, Develops CryoSIM Platform, Published in Top Analytical Chemistry Journal Revolutionizing Oocyte Membrane Permeability Analysis Technology

2026/03/04

The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.

Public Welfare Partnership: A Special Letter from the Jinan Red Cross

2026/02/02

On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).

World’s First Achievement Highlights Brand Leadership

2026/01/19

In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.

Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference

2026/01/04

Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.

2026-10-19

→

Spinning Circuit Systems Directly into Fibers! Woven Robotic Electronic Skin Becomes Possible

The results provide a new underlying technology path for the development of embodied intelligent perception, flexible human-machine interaction, and soft robotics, and are expected to promote the flexible electronics industry from single-point innovation toward systematic application.

2026-10-19

→

Tardigrade Antifreeze Mechanism Achieves 89% Red Blood Cell Recovery

The American Chemical Society (ACS) recently announced that a study published in ACS Applied Materials & Interfaces applied the extreme-environment survival strategies of tardigrades (commonly known as water bears) to red blood cell cryopreservation and restored red blood cell counts in an anemic mouse model.

2026-09-24

→

Light-Speed Thawing of Oocytes: 2D Material + Laser Raises Recovery Survival Rate to 81%

The path validated by this work is clear—allowing samples to rapidly and uniformly traverse the dangerous temperature zone from within to suppress devitrification, providing a useful approach for the cryopreservation of oocytes and even embryos and organs.

2026-09-24

→

Brain Implant Simultaneously Decodes Speech and Gestures, Giving Paralyzed Patients a New Way to “Speak”

However, initial validation has clearly shown that a single brain implant is enough to support multifunctional natural communication, paving the way for paralyzed patients to rebuild an expressive ability that combines speech and gesture.

2026-09-18

→

Nature Breakthrough: Growing a Human Brain in Mice!

The model is expected to accelerate research on diseases such as schizophrenia, epilepsy, autism, and cerebral palsy. However, the road to clinical application remains long, and the dual-track advancement of ethics and science will be key to ensuring steady and sustained progress in this field.

2026-09-18

→

Dressing Cells in an “Antifreeze Coat”: Chlorogenic Acid Can Improve the Cryosurvival Rate of Germline Stem Cells

However, this does not undermine the possibility that adding chlorogenic acid to cryopreservation solutions may be a new strategy for addressing cryopreservation damage in tissues and organs.